MEDICSKIN Forecasts Annual Profit Between 500,000 and 1.5 Million Hong Kong Dollars, Reversing Previous Loss

Stock News
06/12

The company anticipates recording a consolidated profit attributable to its owners in the range of approximately HK$500,000 to HK$1.5 million for the fiscal year ending March 31, 2026. This represents a significant turnaround from the net loss of about HK$3.4 million attributable to owners reported for the corresponding period in the previous year.

The board attributes this shift from loss to profitability primarily to two key factors. Firstly, the group's revenue for the year ending March 31, 2026, has increased compared to the prior year. This growth is credited to a rise in the number of clients using its treatment services and an increase in client visits for these services.

Secondly, the company achieved cost savings during the period. These savings included a reduction in rental expenses, which consequently lowered the depreciation of right-of-use assets, and a decrease in employee-related costs.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10